In silico and in vivo evaluation of the anti-cryptosporidial activity of eugenol
- 1Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia
- 2Special Infectious Agents Unit, King Fahd Medical Research Center, Jeddah, Saudi Arabia
- 3Department of Clinical Microbiology and Immunology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
- 4Biological Sciences Department, College of Sciences and Arts, King Abdulaziz University, Rabigh, Saudi Arabia
- 5Department of Epidemiology, Faculty of Public Health and Health Informatics, Umm Al-Qura University, Mecca, Saudi Arabia
- 6Department of Biology, Faculty of Sciences-Scientific Departments, Qassim University, Buraidah, Saudi Arabia
- 7Department of Zoology, Faculty of Science, Beni-Suef University, Beni Suef, Egypt
- 8Department of Biology, College of Science, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia
- 9Department of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia
- 10Department of Molecular and Cellular Biology, College of Osteopathic Medicine, Sam Houston State University, Conroe, TX, United States
- 11Department of Medical Parasitology, Faculty of Medicine, South Valley University, Qena, Egypt
A corrigendum on
In silico and in vivo evaluation of the anti-cryptosporidial activity of eugenol
by Gattan, H. S., Wakid, M. H., Qahwaji, R. M., Altwaim, S., Mahjoub, H. A., Alfaifi, M. S., Elshazly, H., Al-Megrin, W. A. I., Alshehri, E. A., Elshabrawy, H. A., and El-kady, A. M. (2024). Front. Vet. Sci. 11:1374116. doi: 10.3389/fvets.2024.1374116
In the published article, there was an error in the Funding statement. The funding universities request to add this exact sentence with no changes to grant numbers, only rephrasing the paragraph. This correction is required since this error is going to affect awards disposition at this University.
The correct Funding statement appears below.
Funding
The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. The authors extend their acknowledgement to Princess Nourah bint Abdulrahman University Researchers Supporting Project number (PNURSP2024R39), Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia and Researchers Supporting Project number (RSPD2024R859), King Saud University, Riyadh, Saudi Arabia.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: Cryptosporidium, immunocompromised, eugenol, nitazoxanide, iNOS
Citation: Gattan HS, Wakid MH, Qahwaji RM, Altwaim S, Mahjoub HA, Alfaifi MS, Elshazly H, Al-Megrin WAI, Alshehri EA, Elshabrawy HA and El-kady AM (2024) Corrigendum: In silico and in vivo evaluation of the anti-cryptosporidial activity of eugenol. Front. Vet. Sci. 11:1407833. doi: 10.3389/fvets.2024.1407833
Received: 27 March 2024; Accepted: 22 April 2024;
Published: 08 May 2024.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2024 Gattan, Wakid, Qahwaji, Altwaim, Mahjoub, Alfaifi, Elshazly, Al-Megrin, Alshehri, Elshabrawy and El-kady. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Hatem A. Elshabrawy, hatem.elshabrawy@shsu.edu; Asmaa M. El-kady, asmaa.elkady@med.svu.edu.eg